Clinical Trial Update: Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rofecoxib for hemophilic arthropathy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilic Arthropathy

Drugs mentioned

• Rofecoxib (rofecoxib)

Snippet

Sponsor: Tremeau Pharmceuticals, Inc. | Conditions: Hemophilic Arthropathy | Phase 3 | Status: TERMINATED